Contract Research Organization Companies - Top Emerging Cros

Pharma Tech Outlook: Pharma Tech Magazine

Pro Pharma Group: Customer-Centric Approach to Clinical Research Solutions

Top 10 Emerging CROs - 2022


In 2021, the global contract research organization (CRO) market stood at a market size of 63,590 million dollars. At a CAGR of 11.8 percent, it is expected to reach a valuation of 139,050 million dollars by 2028. This is due to the rising pharmaceutical research and an increasing number of trials done by biotech and pharma companies with the burgeoning of new and unknown diseases. In that regard, CROs are embracing efficient, compliant technology to avoid falling behind. Incorporating remote-site access and patient engagement technology into their daily workflows can let CROs offer impressive patient recruitment, participant retention, and data collection abilities.

Remote technologies like wearable devices and smartphone apps are aiding in collecting participants’ data not only when they are at the research site but also when they are shopping, exercising, or working. This allows researchers to compare how a treatment works in the real world. Real-time data collection also helps them identify adverse events more quickly, keeping participants safer.

Moreover, in a time when 80 percent of clinical trials are delayed due to recruitment difficulties, and up to 50 percent of sites selected for a trial enroll with fewer participants, technology is helping CROs by getting more grounds covered. Technology platforms with remote site access is also allowing CROs to work with locations across the country or worldwide. These software systems give them immediate access to the sites’ documents and data so they can team up with any research site with eligible patients.

At this juncture, there is a variety of leading and emerging CROs that are entering the market to cater to the different needs of the biotech and pharma companies. To choose CROs that best fit their requirement, Pharma Tech Outlook has compiled lists of the top and emerging CROs. Besides, the magazine also comprises insights from thought leaders in the sector on the industry trends, best practices, recent innovations, and their advice for aspiring CIOs.

We present to you Pharma Tech Outlook’s, “Top 10 Emerging CROs – 2022.”

    Top Emerging CROs

  • A CRO provides highly experienced regulatory writing and submission services for biotech and pharmaceutical projects.

  • CL Laboratory is a small CRO founded in 2013 on the principals of excellence, efficiency, and ethics, they are specialized in in-vivo cardiovascular models utilized to advance research at the pre-clinical stage. Their surgical induced heart failure models are at the forefront of their business are reliable, reproducible, and effective for testing novel therapeutics. Using state-of-the-art technology including echocardiograms, and pressure-volume catherization, they are able to provide their clients with many customizable end-points that are vital to drug development.

  • Biomere


    Biomere offers an extensive portfolio of preclinical research services from in vitro analyses, early discovery and proof-of-concept to discovery toxicology. Nonclinical capabilities include: pharmacokinetics, lead compound screening, proof of concept, efficacy assessment, pharmacology, mechanism of action, and early lead optimization. Biomere also provides supportive colony maintenance, backup colony support and on site room use agreements.

  • iQ Biosciences

    iQ Biosciences

    iQ Biosciences provides focused research support to the pharmaceutical, biotechnology, academic, and diagnostic industries in the form of intelligent research services and quality biospecimens. They are driven to go beyond being reliable – they excel at being a trusted partner in the biomedical community to help cure disease by offering Bioservices for Research Testing, Drug Discovery, and Preclinical Studies that can help determine a drug product’s safety and mechanism of action. These services include testing services, in vitro based safety assays, and functional characterization using in vitro assays or in vivo pharmacology models.


    Labcorp is a leading global life sciences company that advances patient health and powers clear, confident decisions through its diagnostics and drug development offerings. With unparalleled diagnostics and drug development capabilities, they accelerate innovation and provide insight to improve health and improve lives.The groups they serve include managed care organizations, biopharmaceutical companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories.

  • Medpace


    Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Their mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.



    NAMSA is the world’s leading MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, they are dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, they are the industry’s premier, trusted partner for successful development and commercialization outcomes.

  • Parexel


    Parexel is one of the world's leading global clinical research organizations (CRO), providing the clinical development capabilities and integrated consulting expertise it takes to streamline development every step of the way — faster and more cost-effectively. They are focused on the development of innovative new therapies to improve the world’s health by providing a suite of groundbreaking biopharmaceutical development services that help customers across the globe transform scientific discoveries into new treatments for patients. From clinical trial design to regulatory and consulting services to commercial and market access, their therapeutic, technical, and functional ability is underpinned by a deep conviction in what they do.

  • PsychoGenics


    PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Their mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development. They are known for their cutting-edge translational approach to research, their customized solutions, the breadth and quality of their work, as well as for their ability to identify statistically relevant phenotypic changes that help their clients quantify the efficacy of their treatments before they move into the clinic.

  • Regen Health Solutions

    Regen Health Solutions

    Regen Health Solutions provides clinical trial related services as a turnkey contract research organization (CRO) to physicians, individual and group private practices, pharmaceutical companies, biotech companies, medical device companies, and clinical sites. They help their clients obtain the best patient outcomes through the advancement of medical science, innovation, and the quality execution of clinical research. They can design and implement a data management system using an optimized CTMS for trial that is fully compliant with industry guidelines and FDA requirements. Their multifaceted infrastructure enables them to support both paper and electronic data capture (EDC) to meet client's unique requirements.